Pharma Journalist -

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI (brexpiprazole) for the treatment of schizophrenia in adults.…
Read More...

Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics announced the initiation of a Phase 1 clinical study to…
Read More...

Imprimis Pharmaceuticals, Inc.an ophthalmology-focused pharmaceutical company announced that it has begun shipping its core sterile ophthalmic medications to select customers from its…
Read More...

Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash. Takeda president and CEO Christophe Weber said: “We are very pleased to…
Read More...

Solasia Pharma K.K. and Lee’s Pharmaceutical Holdings Limited jointly announced that Solasia and Lee’s Pharma have entered into an exclusive agreement for the commercialization and…
Read More...

Mayne Pharma Group Limited announced the launch of butalbital acetaminophen (APAP) tablets 50 mg/300 mg in the United States. Butalbital / APAP is indicated for the treatment of tension…
Read More...

X-Chem, Inc. announced that it has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug…
Read More...

Catalent  announced that it has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency…
Read More...

Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, announced top-line data from its…
Read More...

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv™ (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with…
Read More...